Immediate Impact
54 standout
Citing Papers
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
2024 Standout
Drug repurposing for cancer therapy
2024 Standout
Works of Stephen Scott being referenced
A Population of Heterogeneous Breast Cancer Patient-Derived Xenografts Demonstrate Broad Activity of PARP Inhibitor in BRCA1/2 Wild-Type Tumors
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Stephen Scott | 142 | 174 | 55 | 67 | 27 | 433 | |
| Oya Kavlak | 129 | 71 | 60 | 96 | 59 | 394 | |
| Aslı Göker | 256 | 80 | 153 | 63 | 28 | 492 | |
| Guanjian Li | 100 | 198 | 90 | 76 | 32 | 490 | |
| Chloe Parton | 139 | 57 | 51 | 38 | 23 | 436 | |
| Grace M. Couchman | 154 | 124 | 41 | 29 | 27 | 465 | |
| Janice Bacon | 127 | 89 | 60 | 67 | 36 | 431 | |
| Eva Elmerstig | 89 | 131 | 32 | 96 | 29 | 432 | |
| Meredith Loveless | 179 | 123 | 55 | 90 | 29 | 450 | |
| D. A. Alexander | 95 | 169 | 170 | 48 | 14 | 445 | |
| Hedyeh Riazi | 122 | 57 | 97 | 88 | 58 | 469 |
All Works
Login with ORCID to disown or claim papers
Loading papers...